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SUMMARY The generation of suppression by concanavalin A in peripheral blood mononuclear cells in treated and untreated coeliac subjects using an in vitro assay was found to be significantly increased when compared with controls. The response of peripheral blood mononuclear cells to the plant mitogen concanavalin A (con A) was also significantly depressed in both groups of coeliac patients. It is proposed that the depressed cell mediated immunity found in this and other studies in coeliac patients is because of increased suppression. The possible connection between these findings and the increased incidence of malignancy also found in coeliac disease is discussed.
An association between coeliac disease and intestinal malignancy was recognised in the 30s1 2 and subsequently confirmed. 6 It was then suggested that intestinal malignancy was a complication rather than a coincidental association with coeliac disease.7 This was confirmed by statistical analysis of studies on larger series8 9 which indicated that there might be a similar mechanism underlying both pathologies.
An immunoregulatory abnormality could be responsible for both the malignancy and the depressed cell mediated immunity seen in malignant states and diseases of unknown aetiology such as Hodgkin's disease, systemic lupus erythematosus and coeliac disease.10 Depressed immunity in coeliac disease is suggested by lymphoreticular atrophy11 and depressed lymphocyte transforma- 12 1 tion. 13 Received for publication 12 August 1983 are important in the pathogenesis of a number of disorders and may be of significance in coeliac disease. The purpose of this study was to confirm the observation that cell mediated immunity is depressed in coeliac disease using a lymphocyte transformation assay. An in vitro assay of the generation of suppression was used to examine the hypothesis that an immunoregulatory abnormality is responsible for the depressed cellular immunity and the increased incidence of malignancy associated with coeliac disease. Hank's balanced salt solution and resuspended in RPMI containing 50 p.g/ml of mitomycin C. After incubation for one hour at 37°C in 5% CO2 and 95% humidity, the cells were again washed three times with Hank's balanced salt solution. The concentration of each group of cells was then adjusted to 1 x 106 cells/ml and dispensed in 100 ,ul aliquots into the wells of microculture plates. Equal volumes of autologous peripheral blood mononuclear cells (responders) also at a concentration of 1 x 106 cells/ml, which had been maintained in RPMI at 37°C in 5% CO2 for 24 hours, were added to the mitomycin C treated cells (stimulators). The cocultured cells were or were not stimulated with 1, 2 or 5 ,ug/ml of con A. Each test was carried out in triplicate and cultured for 72 hours.
Methods

TERMINATION OF CULTURES
Twenty four hours before harvesting, 0*3 ,uCi of 3H thymidine (sp.act: 2*0 mCi/ml) was added to each well. At the end of the 72 hour incubation period, the cells were washed onto glass fibre discs using an automatic cell harvester. The discs were suspended in a scintillation cocktail and the amount of cellincorporated 3H thymidine was measured in a scintillation counter.
CALCULATION OF PERCENTAGE SUPPRESSION
The percentage of enhancement or suppression of response to con A by the responders was calculated using the following formula:
where CM" represents counts per minute of peripheral blood mononuclear cells precultured in the presence of con A, mitomycin C treated and added to autologous peripheral blood mononuclear cells in the presence of con A; C" is counts per minute of peripheral blood mononuclear cells precultured in the presence of con A, mitomycin C treated and added to autologous peripheral blood mononuclear cells in the absence of con A; CM is counts per minute of peripheral blood mononuclear cells precultured in the absence of con A, mitomycin C treated and added to autologous peripheral blood mononuclear cells in the presence of con A; C is counts per minute of peripheral blood mononuclear cells precultured in the absence of con A, mitomycin C treated and added to autologous peripheral blood mononuclear cells in the absence of con A.
SUBJECTS
Forty three patients with adult coeliac disease of whom 32 were women, were studied. Ages ranged from 18-66 years with a mean of 28 years. Twenty eight were on gluten free diets and 15 were untreated when tested. All had the characteristic lesion of coeliac disease on jejunal biopsy and a clinical response to the diet of at least six months in the treated patients. The subsequent clinical response of the untreated group to gluten withdrawal confirmed the diagnosis. Twenty of the 43 patients were rebiopsied post treatment and all showed histological improvement in response to the gluten free diet. A control group of 31 normal individuals was also studied.
STATISTICS
The Wilcoxon's test was used to analyse the results.
Results
LYMPHOCYTE TRANSFORMATION (FIG. 1) The response of untreated coeliac peripheral blood mononuclear cells was significantly depressed when compared with normal peripheral blood mononuclear cells at 5 ,ug/ml of con A p<001 and at 2 ,ug/ml of con A p<0-01. At the 1 ,ug/ml dose of con A, the respective mean values of the untreated group and the normal group were also significantly different (p<0.01). The response of treated coeliac peripheral blood mononuclear cells to 5 ,ug/ml and 2 ,ug/ml of con A was also significantly depressed when compared with the normal group p<001. At 1 ,ug/ml con A the mean response of the treated coeliac group was depressed but not significantly so. There was no significant difference between the treated and untreated coeliac groups at any of the three doses of con A. and at 2 ,ug/ml con A (p<OO1). The difference at the 1 ,ug/ml dose of con A was not significant. In treated coeliac peripheral blood mononuclear cells, the mean level of suppression was significantly higher than in normal peripheral blood mononuclear cells at 5 ,ug/ml con A p<O0OO1, at 2 ,ug/ml con A, and the 1 ,ug/ml dose of con A p<O0O1.
There was no significant difference between the degrees of suppression in the treated and untreated coeliac groups. Changes in cell mediated immunity in coeliac generated by con A disease could be secondary to alteration of lymphouclear cells from cyte subpopulations known to occur in this disease. significantly higher Both the proportion and absolute numbers of aIl peripheral blood circulating thymus dependent lymphocytes are )f con A (p<O0OO1) reduced in untreated coeliac disease.2') This depletion may be because of impaired production, increased sequestration in lymphoreticular tissue, or excessive loss into the gut lumen. T cell numbers return to normal, however, after dietary treatment2O 21 hour pre-incubated peripheral blood mononuclear cells may reflect decreased prostaglandin activity28 and not necessarily the loss of suppressor cells. On the other hand, the assay described by Shou and colleagues in which suppressor -cell activity is induced by con A is a system by which the generation of suppression can be measured.29 It is, therefore, a useful technique for examining immunoregulation in disease states.
Discussion
Normal lymphocytes have a surveillance function which is responsible for the recognition and elimination of mutant neoplastic cells in the body.30 Patients with immune deficiencies are known to have an increased risk of malignancy,3' possibly caused by abnormality of immunosurveillance. The depressed cellular immunity and increased suppression seen in this study in coeliac disease could reflect a defect in immunoregulation in vivo which may be responsible for the increased incidence of malignancy in coeliac disease. The results presented here also indicate that the immunoregulatory abnormality is not altered by dietary treatment. In a recent study, when coeliac patients with and without lymphoma were compared, no significant differences were seen between those with histological improvement on the gluten free diet, those who failed to show improvement and those in whom no follow up biopsies were done.32
Increased numbers of suppressor cells have been seen in the peripheral blood of patients with pulmonary sarcoidosis.33 These cells could be responsible for the anergy described in in vitro studies of blood T cells from patients with this disorder.34 35 The ratio of helper to suppressor cells is significantly raised in the lungs of sarcoid patients,33 suggesting that the lung helper cells are derived from the peripheral blood resulting in a depletion of peripheral blood helper cells. 
